Search results for "Papillomavirus"

showing 10 items of 194 documents

Infezione orale da Human papillomavirus: dalla verruca al carcinoma orale. Epidemiologia, clinica, prevenzione e terapia

2015

Riasunto Obiettivi Prendere in esame l’epidemiologia e le manifestazioni cliniche dell’infezione orale da Human papillomavirus (HPV), con particolare attenzione alle lesioni con potenziale oncologico maligno. Materiali e metodi E stata condotta una revisione sistematica della letteratura finalizzata a descrivere lo stato dell’arte in merito all’infezione da HPV nella mucosa orofaringea e alle relative modalita di trasmissione del virus con particolare riferimento alla possibile contemporanea infezione in sedi anatomiche multiple. Vengono approfonditi gli aspetti riguardanti la prevenzione e il controllo dell’infezione mediante la somministrazione di vaccini e lo svolgimento di campagne cono…

Carcinoma of the oropharynxHuman papillomavirubusiness.industryMedicineOrthodonticsHpv testOral SurgeryHuman papillomavirusbusinessHumanitiesSexually transmitted oral infectionHPV vaccineHPV test
researchProduct

Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis

1999

Human papillomavirus (HPV) exists as more than 100 genotypes. It is not well-established whether the different HPV types interfere with infection or pathogenesis by each other. Possible interactions in cervical carcinogenesis between infection with the most common HPV types (6, 11, 16, 18 and 33) were studied in a seroepidemiological case- control study of 218 women with primary untreated cervical cancer and 219 healthy age-matched control women. As previously shown, HPV-16 seropositivity was associated with cervical cancer risk [odds ratio (OR), 2·39], but HPV-16 was not associated with cervical cancer risk among HPV-6 seropositive women (OR, 1·0). The relative excess risk due to interacti…

Cervical cancerHpv typesPapillomavirus InfectionsAbsolute risk reductionUterine Cervical Neoplasmsvirus diseasesOdds ratioBiologyAntibodies Viralmedicine.diseaseVirologyfemale genital diseases and pregnancy complicationsConfidence intervalPathogenesisTumor Virus InfectionsCervical carcinogenesisSeroepidemiologic StudiesCase-Control StudiesVirologyGenotypemedicineHumansFemalePapillomaviridaeJournal of General Virology
researchProduct

976Screening for cervical cancer with Human Papillomavirus testing: stand-alone is preferable over co-testing with cytology

2021

Abstract Background Cervical cancer screening can be conducted with cytology and Human Papillomavirus (HPV) testing but few studies have compared the latter directly to concomitant testing (co-testing). We compared these strategies to determine appropriate screening. Methods Within a randomised population-based cohort study conducted around Mainz, Germany, eligible women (≥30 years) were screened via Pap smear, liquid-based cytology (LBC) and HPV testing (HC2) and HPV genotyped post hoc (PCR). These tests formed three strategies: cytology (Pap or LBC) and HPV (HC2 or PCR) stand-alone and co-testing. Screen positives and 5% negative women were invited to colposcopy. Absolute and relative sen…

Cervical cancerOncologyColposcopymedicine.medical_specialtyRandomizationmedicine.diagnostic_testEpidemiologybusiness.industryGeneral Medicinemedicine.diseaseCervical cancer screeningInternal medicineCytologyMedicineHuman papillomavirusbusinessInternational Journal of Epidemiology
researchProduct

Socioeconomic factors and cervical cancer mortality in Spain during the period 1989?1997

2002

A study was made of cervical cancer (CC) mortality trends in Spain during the period 1989–1997 at National, Autonomous Community and Provincial levels, in relation to different socioeconomic factors. Data were obtained from the Spanish National Institute of Statistics (Instituto Nacional de Estadistica, INE). The crude mortality rates were age-adjusted using the indirect method and Gross Domestic Product (GDP) as socioeconomic status (SES) indicator. National CC age-adjusted mortality rates have increasing slightly, varying from 3.09 deaths/100,000 women in 1989 to 3.42 in 1996. The highest age-adjusted mortality rates corresponded to Seville, Palencia and Orense, with 4.13, 4.06 and 3.98 c…

Cervical cancerbusiness.industryMortality rateUterine Cervical NeoplasmsObstetrics and GynecologyGeneral Medicinemedicine.diseaseGross domestic productSocioeconomic FactorsRisk FactorsSpainRelative riskmedicineHumansFemaleHuman papillomavirusParity (mathematics)Mortality trendsbusinessSocioeconomic statusDemographyDemographyArchives of Gynecology and Obstetrics
researchProduct

On Imported and Domestic Human Papillomavirus Vaccines: Cognition, Attitude, and Willingness to Pay in Chinese Medical Students

2022

This study aimed to analyze the cognition, attitude, and willingness to pay (WTP) for imported and domestic human papillomavirus (HPV) vaccines in Chinese medical students.MethodsMedical students in Eastern, Central and Western China were investigated. We used the HPV cognitive list to measure the cognition of participants and implemented contingent valuation method (CVM) to value WTP. Tobit model was used to analyze the factors associated with WTP.ResultsThe participants' average score for the 21 cognitive questions was 13.05 (±5.09). Among the participants, 60.82 and 88.01% reported that they would wish to be vaccinated and support the partners to be vaccinated. In addition, 92.54% (670) …

ChinaHealth Knowledge Attitudes PracticeStudents MedicalPapillomavirus InfectionsPublic Health Environmental and Occupational HealthUterine Cervical NeoplasmsPatient Acceptance of Health CareMedicareUnited StatesCognitionHumansFemalePapillomavirus VaccinesAgedFrontiers in Public Health
researchProduct

Reorganization of Nuclear Domain 10 Induced by Papillomavirus Capsid Protein L2

2002

AbstractNuclear domains (ND) 10 are associated with proteins implicated in transcriptional regulation, growth suppression, and apoptosis. We now show that the minor capsid protein L2 of human papillomavirus (HPV) type 33 induces a reorganization of ND10-associated proteins. Whereas the promyelocytic leukemia protein, the major structural component of ND10, was unaffected by L2, Sp100 was released from ND10 upon L2 expression. The total cellular amount of Sp100, but not of Sp100 mRNA, decreased significantly, suggesting degradation of Sp100. Proteasome inhibitors induced the dispersal of Sp100 and inhibited the nuclear translocation of L2. In contrast to Sp100, Daxx was recruited to ND10 by …

Co-Repressor ProteinsImmunoprecipitationFluorescent Antibody TechniqueVaccinia virusPromyelocytic Leukemia ProteinAutoantigenspapillomavirusCell LinePromyelocytic leukemia proteinCapsidDeath-associated protein 6DaxxVirologyHumansSp100RNA MessengerAdaptor Proteins Signal TransducingCell NucleusRecombination GeneticbiologyTumor Suppressor ProteinsIntracellular Signaling Peptides and ProteinsNuclear ProteinsND10Signal transducing adaptor proteinAntigens NuclearOncogene Proteins ViralL2biochemical phenomena metabolism and nutritionBlotting NorthernMolecular biologyNeoplasm ProteinsTransport proteinCell biologyProtein TransportProteasomeCapsidbiology.proteinRNACapsid ProteinsFemaleCarrier ProteinsCo-Repressor ProteinsMolecular ChaperonesTranscription FactorsVirology
researchProduct

PVAmpliconFinder: a workflow for the identification of human papillomaviruses from high-throughput amplicon sequencing

2019

Abstract Background The detection of known human papillomaviruses (PVs) from targeted wet-lab approaches has traditionally used PCR-based methods coupled with Sanger sequencing. With the introduction of next-generation sequencing (NGS), these approaches can be revisited to integrate the sequencing power of NGS. Although computational tools have been developed for metagenomic approaches to search for known or novel viruses in NGS data, no appropriate tool is available for the classification and identification of novel viral sequences from data produced by amplicon-based methods. Results We have developed PVAmpliconFinder, a data analysis workflow designed to rapidly identify and classify kno…

Computer scienceComputational biologylcsh:Computer applications to medicine. Medical informaticsBiochemistryWorkflowUser-Computer Interface03 medical and health sciencessymbols.namesakeStructural BiologyHumansVirus discoverylcsh:QH301-705.5PapillomaviridaeMolecular BiologyThroughput (business)PhylogenyAmplicon sequencing030304 developmental biologySanger sequencing0303 health sciencesBiological data030306 microbiologyMethodology ArticleApplied MathematicsHigh-Throughput Nucleotide SequencingPapillomavirusAmpliconComputer Science ApplicationsIdentification (information)Workflowlcsh:Biology (General)MetagenomicsDNA ViralAmplicon sequencingsymbolslcsh:R858-859.7Primer (molecular biology)DNA microarrayBMC Bioinformatics
researchProduct

DNA binding of L1 is required for human papillomavirus morphogenesis in vivo.

2002

AbstractThe role of putative DNA-binding domains of human papillomavirus (HPV) capsid proteins for DNA encapsidation in vivo is still unknown. We have now analyzed mutants of the major capsid protein L1 of HPV type 33, which are defective for DNA binding, for their ability to encapsidate DNA using an in vivo packaging approach. Since the DNA-binding domain and the nuclear localization signal (NLS) of L1 overlap, both a carboxy-terminal deletion mutant (L1-1/470) and a substitution mutant (L1-1/477M9) were analyzed. L1-1/477M9 has the classical NLS replaced by a noncanonical NLS taken from the human hnRNP protein A1. The mutant proteins were defective for DNA binding in contrast to wild-type…

CytoplasmHMG-boxMutantBiologyKidneypapillomavirusCell Linechemistry.chemical_compoundCapsidVirologyHumansPoint MutationDNA bindingPapillomaviridaeInfectivityCell NucleusVirus AssemblypseudovirionsL1DNA encapsidationMolecular biologyChromatinDNA-Binding ProteinschemistryCapsidCytoplasmDNA ViralchromatinDNANuclear localization sequenceVirology
researchProduct

A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes

2005

ABSTRACT Papillomaviruses are internalized via clathrin-dependent endocytosis. However, the mechanism by which viral genomes pass endosomal membranes has not been elucidated. In this report we show that the minor capsid protein L2 is required for egress of viral genomes from endosomes but not for initial uptake and uncoating and that a 23-amino-acid peptide at the C terminus of L2 is necessary for this function. Pseudogenomes encapsidated by L1 and L2 lacking this peptide accumulated in vesicular compartments similar to that observed with L1-only viral particles, and these mutant pseudoviruses were noninfectious. This L2 peptide displayed strong membrane-disrupting activity, induced cytolys…

EndosomevirusesImmunologyMutantMolecular Sequence DataPeptideEndosomesGenome ViralBiologyEndocytosisVirus ReplicationMicrobiologyGreen fluorescent proteinCell LineVirologyAnimalsHumansAmino Acid SequencePapillomaviridaechemistry.chemical_classificationC-terminusStructure and AssemblyPapillomavirus InfectionsMolecular biologyCell biologyMembrane proteinchemistryCapsidInsect ScienceMutationCapsid Proteins
researchProduct

The endocytic trafficking pathway of oncogenic papillomaviruses

2019

Over the last two decades many host cell proteins have been described to be involved in the process of infectious entry of oncogenic human papillomaviruses (HPV). After initial binding and priming of the capsid, a sequence of events on the cell surface precedes the formation of the HPV entry platform. It has been shown that the virus-associated entry complex consists of membrane organizers, tetraspanins CD151 and CD63, and their associated partner proteins such as integrins, growth factor receptors, and the annexin A2 heterotetramer. Further recruitment of cytoplasmic factors such as the obscurin-like protein 1 and actin results in a non-canonical clathrin-independent endocytosis of the vir…

EndosomevirusesIntegrinEndocytic cycleAnnexinEndocytosisArticlelcsh:Infectious and parasitic diseasesEntry receptor complex03 medical and health sciences0302 clinical medicineTetraspaninViral entryVirologyHumansMedicinelcsh:RC109-216030212 general & internal medicineHuman papillomavirus 16Traffickingbiologybusiness.industryPapillomavirus InfectionsBiological TransportVirus InternalizationTetraspaninEndocytosisVirusCell biologyInfectious DiseasesCapsid030220 oncology & carcinogenesisHost-Pathogen Interactionsbiology.proteinbusinessAnnexin A2Papillomavirus Research
researchProduct